Atezolizumab
| CAS No. | 1380723-44-3 | Cat. No. | BCP18055 |
| Name | Atezolizumab | ||
| Synonyms | MPDL3280A; | ||
| Formula | C6446H9902N1706O1998S42 | M. Wt | 144,612.59 g·mol−1 |
| Description | Atezolizumab is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). | ||
| Pathways | Apoptosis Pathway | ||
| Targets | PD 1/PD L1 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.